Literature DB >> 21605047

Mediterranean diet in predementia and dementia syndromes.

V Solfrizzi1, V Frisardi, D Seripa, G Logroscino, B P Imbimbo, G D'Onofrio, F Addante, D Sancarlo, L Cascavilla, A Pilotto, F Panza.   

Abstract

There is a critical need to potentially individualize new strategies able to prevent and to slow down the progression of predementia and dementia syndromes. Only recently higher adherence to a Mediterranean-type diet was associated with decreased cognitive decline although the Mediterranean diet (MeDi) combines several foods, micro- and macronutrients already separately proposed as potential protective factors against dementia and predementia syndromes. In fact, elevated saturated fatty acids could have negative effects on age-related cognitive decline and mild cognitive impairment (MCI). Furthermore, at present, epidemiological evidence suggested a possible association among fish consumption, monounsaturated fatty acids and polyunsaturated fatty acids (PUFA) (particularly, n-3 PUFA) and reduced risk of cognitive decline and dementia. Light to moderate alcohol use may be associated with a reduced risk of incident dementia and Alzheimer's disease (AD), while for vascular dementia, cognitive decline, and predementia syndromes the current evidence is only suggestive of a protective effect. Finally, the limited epidemiological evidence available on fruit and vegetable consumption and cognition generally supported a protective role of these macronutrients against cognitive decline, dementia, and AD. Moreover, recent prospective studies provided evidence that higher adherence to a Mediterranean-type diet could be associated with slower cognitive decline, reduced risk of progression from MCI to AD, reduced risk of AD, and decreased all-causes mortality in AD patients. These findings suggested that adherence to the MeDi may affect not only the risk for AD, but also for predementia syndromes and their progression to overt dementia. Nonetheless, at present, no definitive dietary recommendations are possible. However, high levels of consumption of fats from fish, vegetable oils, non-starchy vegetables, low glycemic fruits, and diet low in foods with added sugars and with moderate wine intake should be encouraged. In fact, this dietary advice is in accordance with recommendations for lowering the risk of cardiovascular disease, obesity, diabetes, and hypertension and might open new ways for the prevention and management of cognitive decline and dementia.

Entities:  

Mesh:

Year:  2011        PMID: 21605047     DOI: 10.2174/156720511796391809

Source DB:  PubMed          Journal:  Curr Alzheimer Res        ISSN: 1567-2050            Impact factor:   3.498


  25 in total

1.  Positive argument for debate in J Neural Transmission: Alzheimer's disease: are we intervening too late? Yes, by years if not decades.

Authors:  Thomas B Shea; Ruth Remington
Journal:  J Neural Transm (Vienna)       Date:  2012-07-11       Impact factor: 3.575

Review 2.  (-)-Phenserine and Inhibiting Pre-Programmed Cell Death: In Pursuit of a Novel Intervention for Alzheimer's Disease.

Authors:  Robert E Becker; Nigel H Greig; Debomoy K Lahiri; Joseph Bledsoe; Sarah Majercik; Clive Ballard; Dag Aarsland; Lon S Schneider; Douglas Flanagan; Ramprakash Govindarajan; Mary Sano; Luigi Ferrucci; Dimitrios Kapogiannis
Journal:  Curr Alzheimer Res       Date:  2018       Impact factor: 3.498

3.  Dietary composition affects the development of cognitive deficits in WT and Tg AD model mice.

Authors:  Inga Kadish; Ashish Kumar; Ulrika Beitnere; Emily Jennings; William McGilberry; Thomas van Groen
Journal:  Exp Gerontol       Date:  2016-05-07       Impact factor: 4.032

Review 4.  Paths to Alzheimer's disease prevention: from modifiable risk factors to biomarker enrichment strategies.

Authors:  S Lista; B Dubois; H Hampel
Journal:  J Nutr Health Aging       Date:  2015-02       Impact factor: 4.075

Review 5.  The nature, significance, and glucagon-like peptide-1 analog treatment of brain insulin resistance in Alzheimer's disease.

Authors:  Konrad Talbot; Hoau-Yan Wang
Journal:  Alzheimers Dement       Date:  2014-02       Impact factor: 21.566

6.  Impact of Single or Repeated Dose Intranasal Zinc-free Insulin in Young and Aged F344 Rats on Cognition, Signaling, and Brain Metabolism.

Authors:  Katie L Anderson; Hilaree N Frazier; Shaniya Maimaiti; Vikas V Bakshi; Zana R Majeed; Lawrence D Brewer; Nada M Porter; Ai-Ling Lin; Olivier Thibault
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2016-04-10       Impact factor: 6.053

Review 7.  Brain insulin resistance in Alzheimer's disease and its potential treatment with GLP-1 analogs.

Authors:  Konrad Talbot
Journal:  Neurodegener Dis Manag       Date:  2014

Review 8.  Alcohol use disorders in the elderly: a brief overview from epidemiology to treatment options.

Authors:  Fabio Caputo; Teo Vignoli; Lorenzo Leggio; Giovanni Addolorato; Giorgio Zoli; Mauro Bernardi
Journal:  Exp Gerontol       Date:  2012-04-10       Impact factor: 4.032

Review 9.  Importance and management of micronutrient deficiencies in patients with Alzheimer's disease.

Authors:  Bárbara Rita Cardoso; Cristiane Cominetti; Silvia Maria Franciscato Cozzolino
Journal:  Clin Interv Aging       Date:  2013-05-10       Impact factor: 4.458

10.  The role of lifestyle behaviors on 20-year cognitive decline.

Authors:  D Cadar; H Pikhart; G Mishra; A Stephen; D Kuh; M Richards
Journal:  J Aging Res       Date:  2012-09-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.